HPV-targeted tumor-infiltrating lymphocytes for cervical cancer.

被引：0
|
作者：
Hinrichs, Christian S.
Stevanovic, Sanja
Draper, Lindsey
Somerville, Robert
Wunderlich, John
Restifo, Nicholas P.
Sherry, Richard
Giao, Phan Q.
Kammula, Udal S.
Yang, James C.
Rosenberg, Steven A.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NCI, Surg Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA3008
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer
    Heppner, Barbara Ingold
    Loibl, Sibylle
    Denkert, Carsten
    BREAST CARE, 2016, 11 (02) : 96 - 100
  • [32] Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer
    Fukui, Kayo
    Masumoto, Norio
    Shiroma, Noriyuki
    Kanou, Akiko
    Sasada, Shinsuke
    Emi, Akiko
    Kadoya, Takayuki
    Yokozaki, Michiya
    Arihiro, Koji
    Okada, Morihito
    BREAST CANCER, 2019, 26 (05) : 573 - 580
  • [33] Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer
    Kayo Fukui
    Norio Masumoto
    Noriyuki Shiroma
    Akiko Kanou
    Shinsuke Sasada
    Akiko Emi
    Takayuki Kadoya
    Michiya Yokozaki
    Koji Arihiro
    Morihito Okada
    Breast Cancer, 2019, 26 : 573 - 580
  • [34] Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer
    Reimann, H.
    Nguyen, A.
    Huebner, H.
    Erber, R.
    Bausenwein, J.
    Van der Meijden, E. D.
    Lux, M. P.
    Jud, S.
    Griffioen, M.
    Rauh, C.
    Sanborn, J. Z.
    Benz, S. C.
    Rabizadeh, S.
    Beckmann, M. W.
    Mackensen, A.
    Ruebner, M.
    Fasching, P. A.
    Kremer, A. N.
    CANCER RESEARCH, 2019, 79 (04)
  • [35] Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) for the treatment of bladder cancer.
    Bunch, Brittany L.
    Morse, Jennifer
    Asby, Sarah
    Poch, Michael
    Pilon-Thomas, Shari
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 31 - 31
  • [36] Tumor-infiltrating lymphocytes in androgen receptor-positive, triple-negative breast cancer.
    Leon-Ferre, Roberto Antonio
    Polley, Mei-Yin
    Liu, Heshan
    Cafourek, Victoria
    Boughey, Judy Caroline
    Kalari, Krishna R.
    Negron, Vivian
    Liu, Minetta C.
    Ingle, James N.
    Couch, Fergus
    Visscher, Daniel W.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [37] TILGen study-immunological targets in patients with breast cancer. Influence of tumor-infiltrating lymphocytes
    Erber, R.
    Hartmann, A.
    Beckmann, M. W.
    Mackensen, A.
    Kremer, A.
    Reimann, H.
    Huebner, H.
    Hein, A.
    Lux, M. P.
    Jud, S.
    Haeberle, L.
    Gass, P.
    Volz, B.
    Schulz-Wendtland, R.
    Ruebner, M.
    Fasching, P. A.
    PATHOLOGE, 2018, 39 : 236 - 240
  • [38] Identification of a neoantigen targeted by tumor-infiltrating lymphocytes in a patient with Her2+breast cancer
    Reimann, H.
    Nguyen, A.
    Huebner, H.
    Erber, R.
    Bausenwein, J.
    Van der Meijden, E. D.
    Lux, M. P.
    Jud, S.
    Griffioen, M.
    Rauh, C.
    Sanborn, J. Z.
    Benz, S. C.
    Rabizadeh, S.
    Beckmann, M. W.
    Mackensen, A.
    Ruebner, M.
    Fasching, P.
    Kremer, A. N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 248 - 248
  • [39] Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy
    Iwata, Takashi
    Nishio, Hiroshi
    Tanaka, Kohsei
    Nakamura, Masaru
    Morisada, Tohru
    Chen, Guanliang
    Katoh, Yuki
    Aoki, Daisuke
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S320
  • [40] ISOLATION AND CHARACTERIZATION OF TUMOR-INFILTRATING LYMPHOCYTES FROM CERVICAL-CARCINOMA
    HILDERS, CGJM
    RAS, L
    VANEENDENBURG, JDH
    NOOYEN, Y
    FLEUREN, GJ
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (06) : 805 - 813
12345